| Date Filed | Type | Description |
| 02/28/2019 |
GN
| Recent Analysis Shows Yamana Gold, Broadcom Inc., Atlas Air Worldwide, Hawaiian, H&E Equipment Services, and Ironwood Pharmaceuticals Market Influences — Renewed Outlook, Key Drivers of Growth |
| 08/09/2018 |
GN
| Factors of Influence in 2018, Key Indicators and Opportunity within Omnicom Group, Ironwood Pharmaceuticals, CorEnergy Infrastructure Trust, Cypress Semiconductor, Yum! Brands, and Zendesk — New Research Emphasizes Economic Growth |
| 05/02/2018 |
BW
| Ironwood Pharmaceuticals Files Definitive Proxy Materials and Mails Letter to Shareholders |
| 05/01/2018 |
BW
| Ironwood Pharmaceuticals Announces Intent to Separate Soluble Guanylate Cyclase (sGC) Business from Commercial and Gastrointestinal Business |
| 05/01/2018 |
BW
| Ironwood Pharmaceuticals Provides First Quarter 2018 Investor Update |
| 04/17/2018 |
BW
| Ironwood Pharmaceuticals to Host First Quarter 2018 Investor Update Call |
| 02/15/2018 |
BW
| Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2017 Investor Update |
| 02/01/2018 |
BW
| Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2017 Investor Update Call |
| 11/06/2017 |
GN
| Market Trends Toward New Normal in Public Service Enterprise Group, Rigel Pharma, National Oilwell Varco, Ironwood Pharma, Express Scripts, and Synergy Pharma – Emerging Consolidated Expectations, Analyst Ratings |
| 11/02/2017 |
BW
| Ironwood Pharmaceuticals Provides Third Quarter 2017 Investor Update |
| 10/19/2017 |
BW
| Ironwood Pharmaceuticals to Host Third Quarter 2017 Investor Update Call |
| 08/03/2017 |
BW
| Ironwood Pharmaceuticals Provides Second Quarter 2017 Investor Update |
| 07/20/2017 |
BW
| Ironwood Pharmaceuticals to Host Second Quarter 2017 Investor Update Call |
| 05/08/2017 |
BW
| Ironwood Pharmaceuticals Provides First Quarter 2017 Investor Update |
| 04/24/2017 |
BW
| Ironwood Pharmaceuticals to Host First Quarter 2017 Investor Update Call |
| 03/10/2017 |
BW
| Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference |
| 03/09/2017 |
BW
| Ironwood Pharmaceuticals Showcases Progress Delivering Innovative Medicines to Patients and Building a Top-Performing Commercial Biotech at R&D Day 2017 |
| 02/21/2017 |
BW
| Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2016 Investor Update |
| 02/07/2017 |
BW
| Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2016 Investor Update Call |
| 09/21/2012 |
PRN
| Linaclotid erhält positive Beurteilung des Ausschusses für Humanarzneimittel zur Behandlung des Reizdarmsyndroms mit Obstipation (IBS-C) |
| 08/11/2011 |
BW
| Ironwood Pharmaceuticals Provides Second Quarter 2011 Investor Update |
| 08/10/2011 |
BW
| Ironwood Pharmaceuticals to Present at Wedbush Securities 2011 Life Sciences Management Access Conference |
| 05/31/2011 |
BW
| Ironwood Pharmaceuticals Announces Upcoming Presentations at Jefferies Global Healthcare Conference and Goldman Sachs Annual Global Healthcare Conference |
| 05/12/2011 |
BW
| Ironwood Pharmaceuticals Provides First Quarter 2011 Investor Update |
| 05/05/2011 |
BW
| Ironwood Pharmaceuticals to Host First Quarter 2011 Investor Update Call |
| 03/03/2011 |
BW
| Ironwood Pharmaceuticals Announces Upcoming Presentation at Cowen and Company Annual Health Care Conference |
| 03/03/2011 |
BW
| Ironwood Pharmaceuticals Provides Fourth Quarter 2010 Investor Update |
| 02/28/2011 |
BW
| Ironwood Pharmaceuticals to Host Fourth Quarter 2010 Investor Update Call |
| 11/05/2010 |
BW
| Ironwood Pharmaceuticals Announces Upcoming Presentation at Credit Suisse 2010 Healthcare Conference |
| 11/04/2010 |
BW
| Ironwood Pharmaceuticals Provides Third Quarter 2010 Investor Update |
| 11/01/2010 |
BW
| Ironwood Pharmaceuticals Announces Conference Call to Discuss Positive Linaclotide Phase 3 IBS-C Results |
| 11/01/2010 |
BW
| Almirall and Ironwood Announce Positive Results from the Second Phase 3 Trial of Linaclotide in Patients with Irritable Bowel Syndrome with Constipation |
| 09/09/2010 |
BW
| Ironwood Pharmaceuticals Announces Upcoming Presentation at Morgan Stanley Global Healthcare Conference |
| 08/02/2010 |
BW
| Ironwood Pharmaceuticals Announces Second Quarter 2010 Investor Update Call |